CAPN10 mRNA splicing and decay is not affected by a SNP associated with susceptibility to type 2 diabetes

Biochemical and Biophysical Research Communications

Volumn 358, Issue 3, 2007, Pages 831-836

  López Orduña, Eduardo ^a,b   García Mena, Jaime ^a   García Macedo, Rebeca ^b   Stumvoll, Michael ^c   Cruz, Miguel ^b  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

CAPN10; Messenger RNA; mRNA decay; Single nucleotide polymorphism; Type 2 diabetes

Indexed keywords

CALPAIN 10; MESSENGER RNA;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE STRUCTURE; HALF LIFE TIME; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; CALPAIN; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; JURKAT CELLS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA PRECURSORS; RNA SPLICING; RNA, MESSENGER;

EID: 34249004537     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.05.001     Document Type: Article

References (33)

1. Grant S.F., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., Helgason A., Stefansson H., Emilsson V., Helgadottir A., Styrkarsdottir U., Magnusson K.P., Walters G.B., Palsdottir E., Jonsdottir T., Gudmundsdottir T., Gylfason A., Saemundsdottir J., Wilensky R.L., Reilly M.P., Rader D.J., Bagger Y., Christiansen C., Gudnason V., Sigurdsson G., Thorsteinsdottir U., Gulcher J.R., Kong A., and Stefansson K. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 38 (2006) 320-323
2. Meyre D., Bouatia-Naji N., Tounian A., Samson C., Lecoeur C., Vatin V., Ghoussaini M., Wachter C., Hercberg S., Charpentier G., Patsch W., Pattou F., Charles M.A., Tounian P., Clement K., Jouret B., Weill J., Maddux B.A., Goldfine I.D., Walley A., Boutin P., Dina C., and Froguel P. Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nat. Genet. 37 (2005) 863-867
3. Love-Gregory L.D., Wasson J., Ma J., Jin C.H., Glaser B., Suarez B.K., and Permutt M.A. A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4a gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an ashkenazi jewish population. Diabetes 53 (2004) 1134-1140
4. Silander K., Mohlke K.L., Scott L.J., Peck E.C., Hollstein P., Skol A.D., Jackson A.U., Deloukas P., Hunt S., Stavrides G., Chines P.S., Erdos M.R., Narisu N., Conneely K.N., Li C., Fingerlin T.E., Dhanjal S.K., Valle T.T., Bergman R.N., Tuomilehto J., Watanabe R.M., Boehnke M., and Collins F.S. Genetic variation near the hepatocyte nuclear factor-4a gene predicts susceptibility to type 2 diabetes. Diabetes 53 (2004) 1141-1149
5. Vasseur F., Helbecque N., Dina C., Lobbens S., Delannoy V., Gaget S., Boutin P., Vaxillaire M., Lepretre F., Dupont S., Hara K., Clement K., Bihain B., Kadowaki T., and Froguel P. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum. Mol. Genet. 11 (2002) 2607-2614
6. Altshuler D., Hirschhorn J.N., Klannemark M., Lindgren C.M., Vohl M.C., Nemesh J., Lane C.R., Schaffner S.F., Bolk S., Brewer C., Tuomi T., Gaudet D., Hudson T.J., Daly M., Groop L., and Lander E.S. The common PPARc Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 26 (2000) 76-80
7. Gloyn A.L., Weedon M.N., Owen K.R., Turner M.J., Knight B.A., Hitman G., Walker M., Levy J.C., Sampson M., Halford S., McCarthy M.I., Hattersley A.T., and Frayling T.M. Large-scale association studies of variants in genes encoding the pancreatic b-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 52 (2003) 568-572
8. Florez J.C., Hirschhorn J., and Altshuler D. The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. Annu. Rev. Genomics Hum. Genet. 4 (2003) 257-291
9. Cruz M., García-Mena J., López-Orduña E., Valladares A., Sánchez R., Wacher-Rodarte N., Aguilar-Gaytan R., and Kumate y.J. Genes candidato como posibles marcadores de susceptibilidad a diabetes tipo 2. Revista de Educación Bioquímica 24 (2005) 81-86
10. Horikawa Y., Oda N., Cox N.J., Li X., Orho-Melander M., Hara M., Hinokio Y., Lindner T.H., Mashima H., Schwarz P.E., del Bosque-Plata L., Horikawa Y., Oda Y., Yoshiuchi I., Colilla S., Polonsky K.S., Wei S., Concannon P., Iwasaki N., Schulze J., Baier L.J., Bogardus C., Groop L., Boerwinkle E., Hanis C.L., and Bell G.I. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 26 (2000) 163-175
11. Altschul S.F., Gish W., Miller W., Myers E.W., and Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 215 (1990) 403-410
12. Benson D.A., Karsch-Mizrachi I., Lipman D.J., Ostell J., and Wheeler D.L. GenBank. Nucleic Acids Res. 34 (2006) D16-D20
13. Burge C., and Karlin S. Prediction of complete gene structures in human genomic DNA. J. Mol. Biol. 268 (1997) 78-94
14. Green R.E., Lewis B.P., Hillman R.T., Blanchette M., Lareau L.F., Garnett A.T., Rio D.C., and Brenner S.E. Widespread predicted nonsense-mediated mRNA decay of alternatively-spliced transcripts of human normal and disease genes. Bioinformatics 19 Suppl 1 (2003) 118-121
15. Hofmann M.A., Schiekofer S., Isermann B., Kanitz M., Henkels M., Joswig M., Treusch A., Morcos M., Weiss T., Borcea V., Abdel Khalek A.K., Amiral J., Tritschler H., Ritz E., Wahl P., Ziegler R., Bierhaus A., and Nawroth P.P. Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-κB. Diabetologia 42 (1999) 222-232
16. Song Y., Niu T., Manson J.E., Kwiatkowski D.J., and Liu S. Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies. Am. J. Hum. Genet. 74 (2004) 208-222
17. Stumvoll M., Fritsche A., Madaus A., Stefan N., Weisser M., Machicao F., and Haring H. Functional significance of the UCSNP-43 polymorphism in the CAPN10 gene for proinsulin processing and insulin secretion in nondiabetic Germans. Diabetes 9 (2001) 2161-2163
18. Carlsson E., Fredriksson J., Groop L., and Ridderstrale M. Variation in the calpain-10 gene is associated with elevated triglyceride levels and reduced adipose tissue messenger ribonucleic acid expression in obese Swedish subjects. J. Clin. Endocrinol. Metab. 89 (2004) 3601-3605
19. Baier L.J., Permana P.A., Yang X., Pratley R.E., Hanson R.L., Shen G.Q., Mott D., Knowler W.C., Cox N.J., Horikawa Y., Oda N., Bell G.I., and Bogardus C. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J. Clin. Invest. 106 (2000) 69-73
20. Yang X., Pratley R.E., Baier L.J., Horikawa Y., Bell G.I., Bogardus C., and Permana P.A. Reduced skeletal muscle calpain-10 transcript level is due to a cumulative decrease in major isoforms. Mol. Genet. Metab. 73 (2001) 111-113
21. Hodges A., Strand A.D., Aragaki A.K., Kuhn A., Sengstag T., Hughes G., Elliston L.A., Hartog C., Goldstein D.R., Thu D., Hollingsworth Z.R., Collin F., and Synek B. Regional and cellular gene expression changes in human Huntington's disease brain. Hum. Mol. Genet. 15 (2006) 965-977
22. Hollams E.M., Giles K.M., Thomson A.M., and Leedman P.J. mRNA stability and the control of gene expression: implications for human disease. Neurochem. Res. 27 (2002) 957-980
23. Leclerc G.J., Leclerc G.M., and Barredo J.C. Real-time RT-PCR analysis of mRNA decay: half-life of Beta-actin mRNA in human leukemia CCRF-CEM and Nalm-6 cell lines. Cancer Cell. Int. 2 (2002)
24. Carlsson E., Poulsen P., Storgaard H., Almgren P., Ling C., Bjørn C.J., Madsbad S., Groop L., Vaag A., and Ridderstråle M. Genetic and nongenetic regulation of CAPN10 mRNA expression in skeletal muscle. Diabetes 54 (2005) 3015-3020
25. Turner M.D., Cassell P.G., and Hitman G.A. Calpain-10: from genome search to function. Diabetes Metab. Res. Rev. 21 (2005) 505-514
26. Smith F.M., Garfield A.S., and Ward A. Regulation of growth and metabolism by imprinted genes. Cytogenet. Genome Res. 113 (2006) 279-291
27. Ross J. mRNA stability in mammalian cells. Microbiol. Rev. 59 (1995) 423-450
28. Fasken M.B., and Corbett A.H. Process or perish: quality control in mRNA biogenesis. Nat. Struct. Mol. Biol. 12 (2005) 482-488
29. Lejeune F., and Maquat L.E. Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells. Curr. Opin. Cell. Biol. 3 (2005) 309-315
30. Maquat L.E. Nonsense-mediated mRNA decay in mammals. J. Cell Sci. 118 (2005) 1773-1776
31. Sato Y., Kuwajima M., Kamiya H., and Harashima H. Calpain-10 is a predictive gene for type 2 diabetes: evidence from a novel screening system using white blood cells of Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Biol. Pharm. Bull. 26 (2003) 1765-1768
32. Prasanth K.V., Prasanth S.G., Xuan Z., Hearn S., Freier S.M., Bennett C.F., Zhang M.Q., and Spector D.L. Regulating gene expression through RNA nuclear retention. Cell 123 (2005) 249-263
33. Clark V.J., Cox N.J., Hammond M., Hanis C.L., and Di Rienzo A. Haplotype structure and phylogenetic shadowing of a hypervariable region in the CAPN10 gene. Hum. Genet. 117 (2005) 258-266